Author:
Zhang Jinhui,Shih Mack,Yan Haoheng,O’Connor Thomas,Ji Chengjie,Faustino Patrick J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference20 articles.
1. Borisov OV AM, Carroll JA, Brown PW. (2015) Sequence variants and sequence variant analysis in biotherapeutic proteins. , in State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization Volume 2 Biopharmaceutical characterization: the NISTmAb case study pp 63–117, ACS Publications.
2. Brady LJ, Scott RA, Balland A. An optimized approach to the rapid assessment and detection of sequence variants in recombinant protein products. Anal Bioanal Chem. 2015;407:3851–60.
3. Easton RL. Structural characterization methods for biosimilars: fit-for-purpose, qualified or validated. Generics and Biosimilars Initiative Journal (GaBI Journal). 2022;11:41–4.
4. FDA (2019) Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other Quality-Related Considerations Guidance for Industry.
5. Frye C, Deshpande R, Estes S, Francissen K, Joly J, Lubiniecki A, Munro T, Russell R, Wang T, Anderson K. Industry view on the relative importance of “clonality” of biopharmaceutical-producing cell lines. Biologicals. 2016;44:117–22.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献